Regenerx Biopharmaceuticals Inc (RGRX)
0.0014
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Regenerx Biopharmaceuticals Total Liabilities (Quarterly): 3.931M for March 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | 3.931M |
| December 31, 2022 | 3.828M |
| September 30, 2022 | 3.722M |
| June 30, 2022 | 3.596M |
| March 31, 2022 | 3.527M |
| December 31, 2021 | 3.515M |
| September 30, 2021 | 3.462M |
| June 30, 2021 | 3.664M |
| March 31, 2021 | 3.435M |
| December 31, 2020 | 3.376M |
| September 30, 2020 | 3.264M |
| June 30, 2020 | 3.217M |
| March 31, 2020 | 3.106M |
| December 31, 2019 | 3.052M |
| September 30, 2019 | 3.011M |
| June 30, 2019 | 3.020M |
| March 31, 2019 | 2.707M |
| December 31, 2018 | 2.493M |
| September 30, 2018 | 2.446M |
| June 30, 2018 | 2.968M |
| March 31, 2018 | 2.903M |
| December 31, 2017 | 4.343M |
| September 30, 2017 | 6.254M |
| June 30, 2017 | 6.000M |
| March 31, 2017 | 6.432M |
| Date | Value |
|---|---|
| December 31, 2016 | 6.929M |
| September 30, 2016 | 7.744M |
| June 30, 2016 | 9.119M |
| March 31, 2016 | 10.06M |
| December 31, 2015 | 7.101M |
| September 30, 2015 | 6.842M |
| June 30, 2015 | 5.682M |
| March 31, 2015 | 4.534M |
| December 31, 2014 | 2.661M |
| September 30, 2014 | 2.528M |
| June 30, 2014 | 3.117M |
| March 31, 2014 | 3.522M |
| December 31, 2013 | 1.664M |
| September 30, 2013 | 1.827M |
| June 30, 2013 | 1.572M |
| March 31, 2013 | 1.598M |
| December 31, 2012 | 1.380M |
| September 30, 2012 | 1.078M |
| June 30, 2012 | 1.218M |
| March 31, 2012 | 1.085M |
| December 31, 2011 | 0.8107M |
| September 30, 2011 | 0.4666M |
| June 30, 2011 | 1.029M |
| March 31, 2011 | 0.6876M |
| December 31, 2010 | 0.6166M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.011M
Minimum
Sep 2019
3.931M
Maximum
Mar 2023
3.420M
Average
3.449M
Median
Total Liabilities (Quarterly) Benchmarks
| FluoroPharma Medical Inc | 10.51M |
| RenovaCare Inc | 2.515M |
| Xeno Transplants Corp | -- |
| Entia Biosciences Inc | 2.406M |
| OncoVista Innovative Therapies Inc | 6.651M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.1868M |
| Shareholders Equity (Quarterly) | -3.744M |